Skip to main content

What the FDA labels say about taking them together

Etonogestrel and ritonavir

Etonogestrel's FDA label of May 28, 2026 names ritonavir in its drug interactions section; the ritonavir label PlainMeds reads does not name etonogestrel. The etonogestrel label: “Significant changes (increase or decrease) in the plasma concentrations of progestin have been noted in cases of co-administration with HIV protease inhibitors or with non-nucleoside reverse transcriptase inhibitors.”

Check it at the source: the etonogestrel FDA label on DailyMed (effective May 28, 2026, Organon LLC); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the etonogestrel label say about ritonavir?

Etonogestrel label, drug interactions

Significant changes (increase or decrease) in the plasma concentrations of progestin have been noted in cases of co-administration with HIV protease inhibitors (decrease [e.g., nelfinavir] or increase [e.g., indinavir, ritonavir and ritonavir-boosted protease inhibitors]) or with non-nucleoside reverse transcriptase inhibitors (decrease [e.g., nevirapine, efavirenz] or increase [e.g., etravirine]).

Source: FDA drug label (Nexplanon), Organon LLC, effective May 28, 2026 (SPL set 487f8a62-e142-457c-97cc-2e398fde7594), via openFDA; the full label on DailyMed

What does the ritonavir label say about etonogestrel?

Ritonavir's label (effective July 23, 2026) does not name etonogestrel in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Etonogestrel generic labelers
7Ritonavir generic labelers
EtonogestrelRitonavir
Labeled forBirth controlHIV
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$0.607 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?